Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$554M |
| 2 |
Broadcom
AVGO
|
+$378M |
| 3 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$324M |
| 4 |
Warner Bros
WBD
|
+$321M |
| 5 |
iShares National Muni Bond ETF
MUB
|
+$315M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio Short Term Treasury ETF
SPTS
|
+$454M |
| 2 |
iShares MBS ETF
MBB
|
+$441M |
| 3 |
AT&T
T
|
+$266M |
| 4 |
State Street SPDR S&P Global Natural Resources ETF
GNR
|
+$198M |
| 5 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$157M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.98% |
| 2 | Healthcare | 13.1% |
| 3 | Financials | 12.8% |
| 4 | Consumer Discretionary | 9.34% |
| 5 | Industrials | 8.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2851
Shore Bancshares
SHBI
$819M
| $859K | ﹤0.01% |
+46,398
| New | +$917K |
|
|
TCDA
2852
DELISTED
Tricida, Inc. Common Stock
TCDA
| $859K | ﹤0.01% |
88,690
+73,159
| +471% | +$696K |
|
2853
Southern First Bancshares
SFST
$591M
| $856K | ﹤0.01% |
19,623
+261
| +1% | +$11.9K |
|
|
NBP
2854
NovaBridge Biosciences American Depositary Shares
NBP
$185M
| $853K | ﹤0.01% |
75,469
+41,743
| +124% | +$500K |
|
|
KLRS
2855
Kalaris Therapeutics
KLRS
$83.5M
| $851K | ﹤0.01% |
9,484
+566
| +6% | +$59.3K |
|
|
ITIC
2856
Investors Title Co
ITIC
$546M
| $849K | ﹤0.01% |
5,411
-67
| -1% | -$11.5K |
|
|
INDT
2857
DELISTED
INDUS Realty Trust, Inc. (MD) Common Stock
INDT
| $848K | ﹤0.01% |
14,271
-1,115
| -7% | -$74.2K |
|
|
BLFY
2858
DELISTED
Blue Foundry Bancorp
BLFY
| $846K | ﹤0.01% |
70,493
-3,731
| -5% | -$46.1K |
|
2859
MVB Financial
MVBF
$397M
| $844K | ﹤0.01% |
27,110
-413
| -2% | -$15.6K |
|
|
VLDR
2860
DELISTED
Velodyne Lidar, Inc. Common Stock
VLDR
| $844K | ﹤0.01% |
883,232
+218,856
| +33% | +$378K |
|
2861
Vera Bradley
VRA
$97M
| $838K | ﹤0.01% |
193,008
+54,881
| +40% | +$335K |
|
2862
Carter Bankshares
CARE
$766M
| $835K | ﹤0.01% |
63,216
-4,358
| -6% | -$66.9K |
|
2863
Sight Sciences
SGHT
$286M
| $835K | ﹤0.01% |
92,814
-9,457
| -9% | -$83.2K |
|
2864
Mirum Pharmaceuticals
MIRM
$6.46B
| $828K | ﹤0.01% |
42,511
+27,011
| +174% | +$637K |
|
|
TEAD
2865
Teads Holding Co
TEAD
$68.7M
| $828K | ﹤0.01% |
164,542
+38,320
| +30% | +$288K |
|
|
IMGO
2866
DELISTED
Imago BioSciences, Inc. Common stock
IMGO
| $822K | ﹤0.01% |
61,315
+13,065
| +27% | +$207K |
|
|
CURO
2867
DELISTED
CURO Group Holdings Corp.
CURO
| $819K | ﹤0.01% |
148,038
-10,520
| -7% | -$96.3K |
|
2868
RBB Bancorp
RBB
$448M
| $818K | ﹤0.01% |
39,566
+2,147
| +6% | +$46.3K |
|
2869
Kornit Digital
KRNT
$705M
| $815K | ﹤0.01% |
25,700
| – | – |
|
2870
State Street SPDR Portfolio TIPS ETF
SPIP
$1.01B
| $815K | ﹤0.01% |
29,617
+4,834
| +20% | +$139K |
|
|
EGIO
2871
DELISTED
Edgio, Inc. Common Stock
EGIO
| $814K | ﹤0.01% |
8,801
+596
| +7% | +$85.8K |
|
|
HDSN
2872
Hudson Technologies
HDSN
$254M
| $810K | ﹤0.01% |
107,774
+94,772
| +729% | +$782K |
|
2873
Kiniksa Pharmaceuticals
KNSA
$5.8B
| $810K | ﹤0.01% |
83,503
+6,421
| +8% | +$59.9K |
|
2874
Expensify
EXFY
$176M
| $809K | ﹤0.01% |
45,473
-1,485
| -3% | -$26.3K |
|
2875
Lexicon Pharmaceuticals
LXRX
$1.03B
| $809K | ﹤0.01% |
434,564
-66,564
| -13% | -$127K |
|
Similar funds
Charles Schwab's Q2 2022 Portfolio in Review
As of Q2 2022, Charles Schwab held 3,742 positions worth $287B, down 14% from $333B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q2 2022 filing shows 162 new, 2,018 increased, 1,243 reduced and 206 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 435,453 shares worth $44.5M. The largest sale was State Street SPDR Portfolio Short Term Treasury ETF, an estimated $454M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.
- Charles Schwab's largest Q2 2022 buy was iShares 7-10 Year Treasury Bond ETF: 435,453 shares worth $44.5M.
- Charles Schwab added most to Cisco in Q2 2022, an estimated $554M increase.
- Charles Schwab's biggest Q2 2022 reduction was State Street SPDR Portfolio Short Term Treasury ETF, cutting an estimated $454M.
- Charles Schwab fully exited Cerner Corp in Q2 2022, selling an estimated $140M.
- Charles Schwab's ten largest holdings make up 17% of its $287B portfolio in Q2 2022.
- Charles Schwab opened 162 new positions and closed 206 in Q2 2022.
- Charles Schwab's portfolio value fell 14% quarter-over-quarter to $287B.
Based on Charles Schwab's 13F filing for Q2 2022, filed 15 Aug 2022.